• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

儿童多发性硬化症

Multiple sclerosis in children.

作者信息

Gadoth Natan

机构信息

Department of Neurology, Meir General Hospital Kfar-Saba, Kfar-Saba 44281, Israel.

出版信息

Brain Dev. 2003 Jun;25(4):229-32. doi: 10.1016/s0387-7604(03)00035-4.

DOI:10.1016/s0387-7604(03)00035-4
PMID:12767451
Abstract

Multiple sclerosis (MS) is traditionally the domain of adult neurologists due to its characteristic presentation during early adult life. Although descriptions of infants with MS appeared in the beginning of the last century and the first autopsy was described even earlier, it was not until 1980 that childhood onset MS was recognized and subsequently well characterized. In spite of this, the awareness of pediatricians and pediatric neurologists to the occurrence of MS especially in infants and young children is still unsatisfactory. It is not infrequent that a meticulous, time consuming and costly search for metabolic and degenerative disorders other that MS is initiated before the diagnosis of MS is considered. This leads to a significant diagnostic and therapeutic delay in many young patients. Moreover, when the presentation is acute and characterized by confusion, seizures, CSF pleocytosis following a viral infection, a diagnosis of meningoencephalitis will be frequently reached. In this review, updated data on frequency, epidemiology, some special clinical and radiological features of childhood onset MS, outcome and treatment will be briefly discussed with the purpose of alerting physicians to the possibility of the occurrence of MS even in infants and young children.

摘要

传统上,多发性硬化症(MS)是成人神经科医生的诊疗范畴,因为其典型症状出现在成年早期。尽管上世纪初就有关于患MS婴儿的描述,甚至更早之前就有首例尸检报告,但直到1980年儿童期发病的MS才得到确认并随后得到充分描述。尽管如此,儿科医生和儿科神经科医生对MS发病情况,尤其是婴儿和幼儿MS发病情况的认知仍不尽人意。在考虑诊断MS之前,常常会对除MS之外的代谢性和退行性疾病展开细致、耗时且昂贵的排查。这导致许多年轻患者出现显著的诊断和治疗延误。此外,当症状急性发作且表现为意识模糊、癫痫发作、病毒感染后脑脊液淋巴细胞增多时,常常会诊断为脑膜脑炎。在本综述中,将简要讨论儿童期发病MS的发病率、流行病学、一些特殊临床和影像学特征、预后及治疗的最新数据,目的是提醒医生即使在婴儿和幼儿中也可能发生MS。

相似文献

1
Multiple sclerosis in children.儿童多发性硬化症
Brain Dev. 2003 Jun;25(4):229-32. doi: 10.1016/s0387-7604(03)00035-4.
2
[Childhood multiple sclerosis and allied demyelinative diseases].
No To Hattatsu. 1999 Jan;31(1):44-7.
3
Acute disseminated encephalomyelitis in childhood: epidemiologic, clinical and laboratory features.儿童急性播散性脑脊髓炎:流行病学、临床及实验室特征
Pediatr Infect Dis J. 2004 Aug;23(8):756-64. doi: 10.1097/01.inf.0000133048.75452.dd.
4
Pediatric Multiple Sclerosis: Distinguishing Clinical and MR Imaging Features.小儿多发性硬化症:临床及磁共振成像特征鉴别
Neuroimaging Clin N Am. 2017 May;27(2):229-250. doi: 10.1016/j.nic.2016.12.007.
5
Atypical inflammatory demyelinating lesions and atypical multiple sclerosis.非典型炎症性脱髓鞘病变和非典型多发性硬化症。
Rev Neurol (Paris). 2018 Jun;174(6):408-418. doi: 10.1016/j.neurol.2018.03.007. Epub 2018 Apr 16.
6
Diagnostic modalities in multiple sclerosis: perspectives in children.多发性硬化症的诊断方法:儿童视角。
Biomed J. 2014 Mar-Apr;37(2):50-9. doi: 10.4103/2319-4170.129269.
7
Pediatric-onset multiple sclerosis in Brazilian patients: Clinical features, treatment response and comparison to pediatric neuromyelitis optica spectrum disorders.巴西患儿多发性硬化症:临床特征、治疗反应及与小儿视神经脊髓炎谱系疾病的比较。
Mult Scler Relat Disord. 2018 Oct;25:138-142. doi: 10.1016/j.msard.2018.07.036. Epub 2018 Jul 20.
8
Common Clinical and Imaging Conditions Misdiagnosed as Multiple Sclerosis: A Current Approach to the Differential Diagnosis of Multiple Sclerosis.被误诊为多发性硬化症的常见临床和影像学病症:多发性硬化症鉴别诊断的当前方法
Neurol Clin. 2018 Feb;36(1):69-117. doi: 10.1016/j.ncl.2017.08.014.
9
Clinical features of children and adolescents with multiple sclerosis.儿童和青少年多发性硬化症的临床特征。
Neurology. 2007 Apr 17;68(16 Suppl 2):S37-45. doi: 10.1212/01.wnl.0000259447.77476.a9.
10
Pediatric multiple sclerosis - current status of epidemiology, diagnosis and treatment.小儿多发性硬化症——流行病学、诊断和治疗的现状。
Neurol Neurochir Pol. 2020;54(6):508-517. doi: 10.5603/PJNNS.a2020.0069. Epub 2020 Sep 17.

引用本文的文献

1
Multiple sclerosis: molecular pathogenesis and therapeutic intervention.多发性硬化症:分子发病机制与治疗干预
Signal Transduct Target Ther. 2025 Oct 2;10(1):324. doi: 10.1038/s41392-025-02415-4.
2
Lipoxins as Modulators of Diseases.脂氧素作为疾病的调节剂。
Cells. 2025 Aug 12;14(16):1244. doi: 10.3390/cells14161244.
3
The epidemiology, pathology and pathogenesis of MS: Therapeutic implications.多发性硬化症的流行病学、病理学及发病机制:治疗意义
Neurotherapeutics. 2025 Feb 27:e00539. doi: 10.1016/j.neurot.2025.e00539.
4
Lower Urinary Tract Dysfunction in Pediatric Patients with Multiple Sclerosis: Diagnostic and Management Concerns.多发性硬化症患儿的下尿路功能障碍:诊断与管理问题
Children (Basel). 2024 May 16;11(5):601. doi: 10.3390/children11050601.
5
Juvenile multiple sclerosis: addressing epidemiology, diagnosis, therapeutic, and prognostic updates along with cognitive dysfunction and quality of life.青少年多发性硬化症:探讨流行病学、诊断、治疗及预后的最新进展,以及认知功能障碍和生活质量。
Ann Med Surg (Lond). 2023 May 25;85(9):4433-4441. doi: 10.1097/MS9.0000000000000930. eCollection 2023 Sep.
6
Personalized Disease Monitoring in Pediatric Onset Multiple Sclerosis Using the Saliva Free Light Chain Test.使用唾液游离轻链检测进行儿科发病多发性硬化的个体化疾病监测。
Front Immunol. 2022 Apr 5;13:821499. doi: 10.3389/fimmu.2022.821499. eCollection 2022.
7
Incidence of Pediatric Multiple Sclerosis in Iran within 2000-2019.2000 - 2019年伊朗儿童多发性硬化症的发病率。
Iran J Child Neurol. 2022 Winter;16(1):31-38. doi: 10.22037/ijcn.v16i1.35572. Epub 2022 Jan 1.
8
Prevalence of Pediatric Onset Multiple Sclerosis in Saudi Arabia.沙特阿拉伯儿童期多发性硬化症的患病率
Mult Scler Int. 2021 Nov 9;2021:4226141. doi: 10.1155/2021/4226141. eCollection 2021.
9
Drugs for Multiple Sclerosis Activate Natural Killer Cells: Do They Protect Against COVID-19 Infection?用于治疗多发性硬化症的药物可激活自然杀伤细胞:它们能预防新冠病毒感染吗?
Infect Drug Resist. 2020 Sep 22;13:3243-3254. doi: 10.2147/IDR.S269797. eCollection 2020.
10
Real-World Safety and Effectiveness of Dimethyl Fumarate in Black or African American Patients with Multiple Sclerosis: 3-Year Results from ESTEEM.富马酸二甲酯在患有多发性硬化症的黑人或非裔美国患者中的真实世界安全性和有效性:来自ESTEEM研究的3年结果
Neurol Ther. 2020 Dec;9(2):483-493. doi: 10.1007/s40120-020-00193-5. Epub 2020 May 29.